Cancer Medicine
-
{
- All
- News
- Videos
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
- Friday November 6, 2026
- Health | Indo Asian News Service
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
www.ndtv.com/health
-
Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers
- Friday October 30, 2026
- India News | Reported by Subham Singh
India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian nations, behind only China.
-
www.ndtv.com
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
- Wednesday October 28, 2026
- Health | Reported by Tanushka Dutta
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
www.ndtv.com/health
-
Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources
- Thursday October 8, 2026
- Health | Reported by Tanushka Dutta, Edited by Debosmita Ghosh
According to official sources in the Department of Pharmaceuticals, the new measure is expected to result in reductions of up to 70% in the MRP of certain cancer medicines. The government estimates that the move could lead to annual savings of around Rs 2,500 crore for patients.
-
www.ndtv.com/health
-
'Daylight Robbery Of Patients': Supreme Court Slams 10-Fold Gap In Cancer Drug Prices
- Tuesday September 22, 2026
- Health | Edited by Debosmita Ghosh
The Court expressed displeasure over the disparity in prices and described it as a serious issue affecting patients.
-
www.ndtv.com/health
-
Access To 12 Childhood Cancer Medicines Will Be Made Easier Globally: WHO
- Friday September 18, 2026
- Health | Written by Sambhav Kumar
WHO launches a new pathway inviting manufacturers to submit childhood cancer medicines for evaluation under its Prequalification Programme.
-
www.ndtv.com/health
-
Deadly "Pharaoh's Curse" Fungus Can Help Fight Cancer, New Study Finds
- Monday June 23, 2025
- Feature | Edited by Srishti Singh Sisodia
The researchers studied many strains of Aspergillus flavus and found that they might contain more of the chemicals.
-
www.ndtv.com
-
World Cancer Day 2025: Try These Natural Sources Of Anti-Cancer Drugs
- Monday February 3, 2025
- Health | Aayushi Singh Chauhan
World Cancer Day 2025: This article explores various natural sources of anti-cancer drugs, their mechanisms, and how they could contribute to preventing or treating cancer.
-
www.ndtv.com/health
-
Several Anti-Cancer Drugs, Antibiotics, Now "Essential Medicines", To Be Cheaper
- Tuesday September 13, 2022
- India News | Press Trust of India
Several anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List of Essential Medicines, with the government saying this will reduce "patients' out-of-pocket expenditure".
-
www.ndtv.com
-
34 Drugs, Including Anti-Cancer Medication, Added To National Essential Medicines List
- Tuesday September 13, 2022
- India News | Press Trust of India
Thirty-four drugs, including some anti-infectives such as Ivermectin, Mupirocin and Nicotine Replacement Therapy, have been added to the National List of Essential Medicines taking the total drugs under it to 384.
-
www.ndtv.com
-
Government Defends Right To Issue Drug "Compulsory Licences"
- Wednesday March 23, 2016
- Thomson Reuters
India has defended its right to grant licences allowing local firms to override patents and make cheaper copies of drugs discovered by big Western drugmakers, and said reports to the contrary were "factually incorrect".
-
www.ndtvprofit.com
-
Drug Defies A Rare Form Of Cancer - And Market Logic
- Thursday March 10, 2016
- World News | Carolyn Y Johnson, The Washington Post
When the drug company Novartis launched its breakthrough cancer medicine, Gleevec, in 2001, the list price was $26,400 a year. The company's chief executive acknowledged it was expensive, calling it an "uphill battle to win understanding for our decision."
-
www.ndtv.com
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
- Friday November 6, 2026
- Health | Indo Asian News Service
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
www.ndtv.com/health
-
Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers
- Friday October 30, 2026
- India News | Reported by Subham Singh
India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian nations, behind only China.
-
www.ndtv.com
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
- Wednesday October 28, 2026
- Health | Reported by Tanushka Dutta
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
www.ndtv.com/health
-
Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources
- Thursday October 8, 2026
- Health | Reported by Tanushka Dutta, Edited by Debosmita Ghosh
According to official sources in the Department of Pharmaceuticals, the new measure is expected to result in reductions of up to 70% in the MRP of certain cancer medicines. The government estimates that the move could lead to annual savings of around Rs 2,500 crore for patients.
-
www.ndtv.com/health
-
'Daylight Robbery Of Patients': Supreme Court Slams 10-Fold Gap In Cancer Drug Prices
- Tuesday September 22, 2026
- Health | Edited by Debosmita Ghosh
The Court expressed displeasure over the disparity in prices and described it as a serious issue affecting patients.
-
www.ndtv.com/health
-
Access To 12 Childhood Cancer Medicines Will Be Made Easier Globally: WHO
- Friday September 18, 2026
- Health | Written by Sambhav Kumar
WHO launches a new pathway inviting manufacturers to submit childhood cancer medicines for evaluation under its Prequalification Programme.
-
www.ndtv.com/health
-
Deadly "Pharaoh's Curse" Fungus Can Help Fight Cancer, New Study Finds
- Monday June 23, 2025
- Feature | Edited by Srishti Singh Sisodia
The researchers studied many strains of Aspergillus flavus and found that they might contain more of the chemicals.
-
www.ndtv.com
-
World Cancer Day 2025: Try These Natural Sources Of Anti-Cancer Drugs
- Monday February 3, 2025
- Health | Aayushi Singh Chauhan
World Cancer Day 2025: This article explores various natural sources of anti-cancer drugs, their mechanisms, and how they could contribute to preventing or treating cancer.
-
www.ndtv.com/health
-
Several Anti-Cancer Drugs, Antibiotics, Now "Essential Medicines", To Be Cheaper
- Tuesday September 13, 2022
- India News | Press Trust of India
Several anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List of Essential Medicines, with the government saying this will reduce "patients' out-of-pocket expenditure".
-
www.ndtv.com
-
34 Drugs, Including Anti-Cancer Medication, Added To National Essential Medicines List
- Tuesday September 13, 2022
- India News | Press Trust of India
Thirty-four drugs, including some anti-infectives such as Ivermectin, Mupirocin and Nicotine Replacement Therapy, have been added to the National List of Essential Medicines taking the total drugs under it to 384.
-
www.ndtv.com
-
Government Defends Right To Issue Drug "Compulsory Licences"
- Wednesday March 23, 2016
- Thomson Reuters
India has defended its right to grant licences allowing local firms to override patents and make cheaper copies of drugs discovered by big Western drugmakers, and said reports to the contrary were "factually incorrect".
-
www.ndtvprofit.com
-
Drug Defies A Rare Form Of Cancer - And Market Logic
- Thursday March 10, 2016
- World News | Carolyn Y Johnson, The Washington Post
When the drug company Novartis launched its breakthrough cancer medicine, Gleevec, in 2001, the list price was $26,400 a year. The company's chief executive acknowledged it was expensive, calling it an "uphill battle to win understanding for our decision."
-
www.ndtv.com